Blue Jay Capital Management as of March 31, 2017
Portfolio Holdings for Blue Jay Capital Management
Blue Jay Capital Management holds 21 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Tesaro | 6.4 | $13M | 85k | 153.87 | |
| Biogen Idec (BIIB) | 6.2 | $13M | 46k | 273.42 | |
| Globus Med Inc cl a (GMED) | 5.8 | $12M | 400k | 29.62 | |
| Ironwood Pharmaceuticals (IRWD) | 5.7 | $12M | 675k | 17.06 | |
| Qiagen | 5.5 | $11M | 390k | 28.97 | |
| Bristol Myers Squibb (BMY) | 5.3 | $11M | 200k | 54.38 | |
| Clovis Oncology | 4.7 | $9.6M | 150k | 63.67 | |
| Wright Medical Group Nv | 4.7 | $9.5M | 306k | 31.12 | |
| Abiomed | 4.6 | $9.4M | 75k | 125.20 | |
| Nevro (NVRO) | 4.6 | $9.4M | 100k | 93.70 | |
| Incyte Corporation (INCY) | 4.6 | $9.3M | 70k | 133.67 | |
| C.R. Bard | 4.6 | $9.3M | 37k | 248.54 | |
| BioMarin Pharmaceutical (BMRN) | 4.5 | $9.2M | 105k | 87.78 | |
| NuVasive | 4.5 | $9.2M | 123k | 74.68 | |
| Pra Health Sciences | 4.5 | $9.1M | 140k | 65.23 | |
| Celgene Corporation | 4.5 | $9.1M | 73k | 124.43 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 4.3 | $8.8M | 80k | 109.35 | |
| Edwards Lifesciences (EW) | 4.2 | $8.5M | 90k | 94.07 | |
| Allscripts Healthcare Solutions (MDRX) | 3.7 | $7.5M | 590k | 12.68 | |
| Akorn | 3.5 | $7.2M | 300k | 24.08 | |
| Dermira | 3.5 | $7.2M | 210k | 34.11 |
